Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by de Chadarévian, J.-P.
Right arrow Articles by Katsetos, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Chadarévian, J.-P.
Right arrow Articles by Katsetos, C. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBAMAZEPINE
Medline Plus Health Information
*Coronary Artery Disease
*Epilepsy
*Heart Attack
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Epilepsy, Atherosclerosis, Myocardial Infarction, and Carbamazepine

Jean-Pierre de Chadarévian, MD

Department of Pathology and Laboratory Medicine, Drexel University College of Medicine and St. Chritopher's Hospital for Children, Philadelphia, Pennsylvania, JD37{at}drexel.edu

Agustin Legido, MD

Department of Pediatrics, Section of Pediatric Neurology, Drexel University College of Medicine and St. Chritopher's Hospital for Children, Philadelphia, Pennsylvania

Daniel K. Miles, MD

Department of Pediatrics, Section of Pediatric Neurology, Drexel University College of Medicine and St. Chritopher's Hospital for Children, Philadelphia, Pennsylvania

Christos D. Katsetos, MD

Department of Pathology and Laboratory Medicine Department of Pediatrics, Section of Pediatric Neurology Drexel University College of Medicine and St. Christopher's Hospital for Children, Philadelphia, Pennsylvania

Epileptic patients receiving medications such as phenytoin or phenobarbital have been noted to have an exceedingly low incidence of myocardial infarction, but children treated with carbamazepine have shown alteration of their serum lipid profile that could predispose them to atherosclerosis. This report seems to corroborate this point and describes the findings in an 11-year-old boy who died following a major seizure, rhabdomyolysis, and renal failure. The autopsy demonstrated that he had marked coronary atherosclerosis and myocardial infarction. The child had been treated with carbamazepine for more than 10 years. (J Child Neurol 2003;18: 150—151).

Journal of Child Neurology, Vol. 18, No. 2, 150-151 (2003)
DOI: 10.1177/08830738030180021301


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?